Displaying items 13-24 of 175
» View wsbtradio.com items only
< Previous
1
2
3
4
5
6
7
8
9
10
11-15
Next >
-
Divisive Elan boss Martin faces ownership showdown
ReutersDUBLIN/NEW YORK (Reuters) - When Kelly Martin, a former Merrill Lynch banker with no drug industry experience, took over as CEO of Ireland's Elan in 2003, analysts assumed his mandate was to clean up the troubled company and sell it. But 10 years later,...Tags: Companies and Corporations, Shareholders, Chemical Industry, Food and Drug Administration, Economy, Business and Finance
-
CORRECTED-(OFFICIAL)-Royalty wants Elan appeal heard next week
Reuters(Elan corrects statement to show share price has almost trebled, not more than trebled since Schuler's resignation announced, para 13) DUBLIN, June 12 (Reuters) - U.S.-based Royalty Pharma sought to have an appeal heard next week over conditions attached...Tags: Shareholders, Republic of Ireland, Dublin (Ireland)
-
Royalty wants appeal over Elan bid heard next week
ReutersDUBLIN, June 12 (Reuters) - U.S.-based Royalty Pharma sought to have an appeal heard next week over conditions attached to its hostile bid for Irish drug firm Elan that threaten to scupper the $8 billion deal. Royalty received a blow in its battle to...Tags: Shareholders, Republic of Ireland, Dublin (Ireland)
-
Royalty pursuing hostile bid for Elan, fights Irish panel ruling
ReutersNEW YORK, June 11 (Reuters) - Royalty Pharma, pursuing a hostile $8 billion takeover of Irish drugmaker Elan Corp Plc, moved on Tuesday to make sure it is not blocked by a potential $200 million share buyback and drug spinoff at the target company. Elan,...Tags: Companies and Corporations, Shareholders, Theravance Incorporated, Stock Activities, Multiple Sclerosis
-
DEALTALK-Elan's share buyback in focus as it fights $8 bln takeover
ReutersBy Soyoung Kim and Jessica Toonkel NEW YORK, June 10 (Reuters) - For Elan Corp Plc's stockholders, a proposed share buyback may not be as friendly as it appears. The Irish drugmaker, in the middle of an increasingly bitter and complicated fight against...Tags: Companies and Corporations, Mergers, Acquisitions and Takeovers, Shareholders, Theravance Incorporated, Politics
-
U.S. RESEARCH ROUNDUP: Visa, Moody's, Facebook, BNY Mellon
ReutersJune 10 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies including 3M and Facebook on Monday. HIGHLIGHTS * BNY Mellon : Raymond James raises price target to $33 from $31 * Western Union Co :...Tags: Weight, Ritchie Bros. Auctioneers Incorporated, First Bancorp, Edison International, Illumina, Inc.
-
Elan rechaza nueva oferta de Royalty Pharma, evalúa interés de otras empresas
ReutersPor Sophie Sassard LONDRES (Reuters) - La farmacéutica irlandesa Elan atrajo el interés de varias compañías de medicamentos y una oferta en efectivo de 15,50 dólares por acción podría ser suficiente para obtener su respaldo, dijo el lunes una...Tags: Citigroup Incorporated
-
Elan voluntarily dismisses U.S. lawsuit against Royalty
ReutersNEW YORK, June 10 (Reuters) - Irish drug firm Elan Corp Plc voluntarily dismissed its U.S. lawsuit against Royalty Pharma, the U.S. investment firm which increased its offer to take over Elan last week, a court filing showed on Monday. In a filing in U....Tags: Manhattan (New York City), Crime, Law and Justice, Justice System
-
DEALTALK-Tax leverage helps make Irish pharma a popular target
Reuters* Elan has interested buyers * Shire, Jazz could be attractive targets -sources * Deals breed deals when it comes to lower taxes By Jessica Toonkel NEW YORK, June 10 (Reuters) - Irish pharmaceutical companies are becoming increasingly popular takeover...Tags: Mergers, Acquisitions and Takeovers, Companies and Corporations, Science and Technology, Drugs and Medicines, Chemical Industry
-
Miners drag on European shares on weak China data
Reuters* FTSEurofirst 300 flat at 1,194.90 * Miners fall 1.6 pct after weak China data * Drugmakers boosted by M&A, Elan rejects offer By David Brett LONDON, June 10 (Reuters) - European shares were flat by midday on Monday with an attempt to rally capped by...Tags: AstraZeneca Plc, Federal Reserve, China
-
Royalty Pharma urges U.S. court to let Elan bid proceed
ReutersBy David Henry and Nate Raymond NEW YORK, June 9 (Reuters) - Investment partnership Royalty Pharma on Sunday urged a federal court in New York to allow it to proceed with a potential $8 billion bid for Irish drug company Elan Corp. In a brief...Tags: Manhattan (New York City), Multiple Sclerosis, Republic of Ireland
-
Miners drag European shares down after China data
Reuters* FTSEurofirst 300 fell 0.1 pct to 1193.45 * Miners knocked as China growth loses steam * Volatility to remain into FOMC meet next week * Elan leads drugmakers up on M&A talk By David Brett LONDON, June 10 (Reuters) - Mining stocks were the top...Tags: AstraZeneca Plc, Federal Reserve, Metal and Mineral, Mining, China
Jun 13, 2013
|Story| Reuters
Jun 12, 2013
|Story| Reuters
Jun 12, 2013
|Story| Reuters
Jun 11, 2013
|Story| Reuters
Jun 10, 2013
|Story| Reuters
Jun 10, 2013
|Story| Reuters
Jun 10, 2013
|Story| Reuters
Jun 10, 2013
|Story| Reuters
Jun 10, 2013
|Story| Reuters
Jun 10, 2013
|Story| Reuters
Jun 9, 2013
|Story| Reuters
Jun 10, 2013
|Story| Reuters
Original site for Elan Corporation Plc topic gallery.